Allochimeric therapy induces unique regulatory T cells that mitigate chronic rejection

Transplantation Proceedings

Volumn 37, Issue 1, 2005, Pages 35-36

  Semiletova, N V ^a   Shen, X D ^a   Slomowitz, S J ^a   Baibakov, B ^b   Feldman, D M ^a   Busuttil, R W ^a   Kupiec Weglinski, J W ^a   Ghobrial, R M ^a  

^a UCLA MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN;

ALLOIMMUNITY; ALPHA HELIX; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL MODEL; CARDIAC GRAFT REJECTION; CELL FUNCTION; CHIMERA; CONFERENCE PAPER; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DONOR; DOWN REGULATION; DRUG MEGADOSE; GENETIC TRANSFECTION; HEART GRAFT; HISTOLOGY; HOST CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; RAT; RECIPIENT; T LYMPHOCYTE ACTIVATION; TECHNIQUE; TREATMENT OUTCOME;

EID: 16244423008     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.12.061     Document Type: Conference Paper

References (2)

1. E. Chiffoleau, P.T. Walsh, L. Turka Apoptosis and transplantation tolerance Immunological Reviews 193 2003 124
2. N. Semiltova, X.D. Shen, M.C. Fishbein Posttransplant administration of allochimeric major histocompatibility complex class-I molecules induces true transplantation tolerance Transplantation 75 2003 550